[Expression of lymphocyte activation markers in patients with gastrointestinal tumors at different stages].
Patients with gastrointestinal tumors revealed relatively high levels of activated lymphocytes. CD25 expression at later stages was much higher than at earlier ones (I-II). A relationship between CD25, CD71 and CD95 expression was established for metastatic spread of gastrointestinal tumors as well as a correlation between CD71 and CD98 expression for favorable course. A distinct activation phenotype can be identified for peripheral blood lymphocytes in burgeoning tumor which should be taken into account in prognosis.
Oleĭnik
E K
EK
Shibaev
M I
MI
Oleĭnik
V M
VM
D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D015179:Colorectal Neoplasms / Q000097:blood / Q000473:pathology; D005260:Female; D027261:Fusion Regulatory Protein-1 / Q000097:blood; D005770:Gastrointestinal Neoplasms / Q000097:blood* / Q000473:pathology*; D006684:HLA-DR Antigens / Q000097:blood; D006801:Humans; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D015375:Receptors, Interleukin-2 / Q000097:blood; D011990:Receptors, Transferrin / Q000097:blood; D013274:Stomach Neoplasms / Q000097:blood / Q000473:pathology; D019014:fas Receptor / Q000097:blood
D015703:Antigens, CD; D014408:Biomarkers, Tumor; C068126:CD71 antigen; D027261:Fusion Regulatory Protein-1; D006684:HLA-DR Antigens; D015375:Receptors, Interleukin-2; D011990:Receptors, Transferrin; D019014:fas Receptor